157 related articles for article (PubMed ID: 3498702)
1. In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
Mulligan ME
Infect Control; 1987 Jun; 8(6):241-4. PubMed ID: 3498702
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
Kumar A; Kelly KJ
Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
[TBL] [Abstract][Full Text] [Related]
4. [Resistance patterns of certain Enterobacteriaceae in hospital and outpatients, with particular reference to trimethoprim-sulfamethoxazole (author's transl)].
Freitag V
MMW Munch Med Wochenschr; 1976 Feb; 118(9):275-8. PubMed ID: 817195
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefixime (FK 027) for resistant gram-negative bacilli.
Smith SM; Eng RH
Chemotherapy; 1988; 34(6):455-61. PubMed ID: 3243091
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
7. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
[TBL] [Abstract][Full Text] [Related]
8. Microbiological perspectives of co-trimoxazole.
Bauernfeind A; Hörl G; Przyklenk B
Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
[TBL] [Abstract][Full Text] [Related]
9. [Is resistance to antibiotics changing? Development of resistance of Enterobactericeae from specimens 1977-1980].
Cullmann W; Opferkuch W; Schäfer D; Stieglitz M
Fortschr Med; 1982 Feb; 100(7):260-4. PubMed ID: 6918353
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Hamilton-Miller JM; Brumfitt W
Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
[TBL] [Abstract][Full Text] [Related]
12. Resistance to antibiotics in clinical isolates of Klebsiella pneumoniae.
O'Brien TF; Mayer KH; Hopkins JD; Farrell JJ; Chao L; Kent RL
Infect Control; 1985 Feb; 6(2):64-7. PubMed ID: 3882592
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
Peeters M; Piot P
J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
[TBL] [Abstract][Full Text] [Related]
14. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of the new oral cephalosporin cefixime.
Counts GW; Baugher LK; Ulness BK; Hamilton DJ
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):428-31. PubMed ID: 3137053
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Philippon A; Jarlier V; Legrand P; Fournier G; Nicolas MH; Duval J
Presse Med; 1989 Oct; 18(32):1560-6. PubMed ID: 2530532
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
19. In-vitro studies with ceftazidime.
Giamarellou H; Avlami A; Matsakas V; Kosmidis J; Daikos GK
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():73-7. PubMed ID: 19802972
[TBL] [Abstract][Full Text] [Related]
20. Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
Meyer RD; Liu S
Diagn Microbiol Infect Dis; 1987 Mar; 6(3):199-206. PubMed ID: 3105948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
